Related references
Note: Only part of the references are listed.Oligodendroglia: new players in amyotrophic lateral sclerosis
Albert C. Ludolph
BRAIN (2013)
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
Thomas Philips et al.
BRAIN (2013)
Sigma-1 Receptor Knockout Impairs Neurogenesis in Dentate Gyrus of Adult Hippocampus Via Down-Regulation of NMDA Receptors
Sha Sha et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro
Joyce A. Benjamins et al.
GLIA (2013)
A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination
Cui Li et al.
GLIA (2013)
NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury
Marie T. Fischer et al.
BRAIN (2012)
Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice
E. Griesmaier et al.
EXPERIMENTAL NEUROLOGY (2012)
The Lifetime of UDP-galactose: Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones
Teruo Hayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
Robert P. Lisak et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Disruption of NMDA Receptors in Oligodendroglial Lineage Cells Does Not Alter Their Susceptibility to Experimental Autoimmune Encephalomyelitis or Their Normal Development
Fuzheng Guo et al.
JOURNAL OF NEUROSCIENCE (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors
Yunsung Nam et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Sigma-1 Receptor Agonists Directly Inhibit NaV1.2/1.4 Channels
Xiao-Fei Gao et al.
PLOS ONE (2012)
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Michiko Fujimoto et al.
SYNAPSE (2012)
The sigma-1 receptor: roles in neuronal plasticity and disease
Said Kourrich et al.
TRENDS IN NEUROSCIENCES (2012)
A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
Amr Al-Saif et al.
ANNALS OF NEUROLOGY (2011)
Oxidative damage in multiple sclerosis lesions
Lukas Haider et al.
BRAIN (2011)
Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats
Shiou-Lan Chen et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Current Concepts in the Pharmacotherapy of Pseudobulbar Affect
Erik P. Pioro
DRUGS (2011)
The molecular basis of neurodegeneration in multiple sclerosis
Hans Lassmann et al.
FEBS LETTERS (2011)
NMDA Receptor Signaling in Oligodendrocyte Progenitors Is Not Required for Oligodendrogenesis and Myelination
Lindsay M. De Biase et al.
JOURNAL OF NEUROSCIENCE (2011)
Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
Olga V. Chechneva et al.
NEUROBIOLOGY OF DISEASE (2011)
A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
O. Gredal et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Dextromethorphan Plus Ultra Low-Dose Quinidine Reduces Pseudobulbar Affect
Erik P. Pioro et al.
ANNALS OF NEUROLOGY (2010)
Sigma Nonopioid Intracellular Receptor 1 Mutations Cause Frontotemporal Lobar Degeneration-Motor Neuron Disease
Agnes A. Luty et al.
ANNALS OF NEUROLOGY (2010)
Current Hypotheses for the Underlying Biology of Amyotrophic Lateral Sclerosis
Jeffrey D. Rothstein
ANNALS OF NEUROLOGY (2009)
Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway
Issa P. Bagayogo et al.
ASN NEURO (2009)
Sigma Receptors Suppress Multiple Aspects of Microglial Activation
Aaron A. Hall et al.
GLIA (2009)
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures
Robert P. Lisak et al.
JOURNAL OF NEUROINFLAMMATION (2009)
The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
Eniko Vamos et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
The pharmacology of sigma-1 receptors
Tangui Maurice et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Glutamate receptor expression in multiple sclerosis lesions
Jia Newcombe et al.
BRAIN PATHOLOGY (2008)
Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice
Adam Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Dextromethorphan is protective against sensitized N-methyl-D-aspartate receptor-mediated excitotoxic brain damage in the developing mouse brain
Matthias Keller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Signal transduction pathways involved in interaction of galactosylceramide/sulfatide-containing liposomes with cultured oligodendrocytes and requirement for myelin basic protein and glycosphingolipids
Joan M. Boggs et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity
R. E. Gonsette
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
DEXTROMETHORPHAN/QUINIDINE SULFATE FOR PSEUDOBULBAR AFFECT
Howard Rosen
DRUGS OF TODAY (2008)
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins
Robert P. Lisak et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
Therapeutic use of dextromethorphan: Key learnings from treatment of pseudobulbar affect
Ariel Miller et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
Katalin Sas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Dextromethorphan: A review of N-methyl-D-aspartate receptor antagonist in the management of pain
Anita Siu et al.
CNS DRUG REVIEWS (2007)
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action
Linda L. Werling et al.
NEUROLOGIST (2007)
Remyelination is extensive in a subset of multiple sclerosis patients
Peter Patrikios et al.
BRAIN (2006)
Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology
Arthur M. Butt
GLIA (2006)
Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis
HS Panitch et al.
ANNALS OF NEUROLOGY (2006)
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures
RP Lisak et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil
JF Marier et al.
LIFE SCIENCES (2005)
MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity
DM Thomas et al.
BRAIN RESEARCH (2005)
Implications for the Kynurenine Pathway and Quinolinic Acid in Amyotrophic Lateral Sclerosis
Gilles J. Guillemin et al.
NEURODEGENERATIVE DISEASES (2005)
Influence of concomitant quinidine administration on dextromethorphan disposition in rats
JF Marier et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Sigma receptors: biology and therapeutic potential
X Guitart et al.
PSYCHOPHARMACOLOGY (2004)
Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation
T Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Glutamate uptake by oligodendrocytes - Implications for excitotoxicity in multiple sclerosis
D Pitt et al.
NEUROLOGY (2003)
Understanding the molecular mechanism of sigma-1 receptors: Towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction
TP Su et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Nitric oxide as an activity marker in multiple sclerosis
G Acar et al.
JOURNAL OF NEUROLOGY (2003)
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation
YX Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Immunohistochemical localization of the σ1-receptor in oligodendrocytes in the rat central nervous system
G Palacios et al.
BRAIN RESEARCH (2003)
The role of nitric oxide in multiple sclerosis
KJ Smith et al.
LANCET NEUROLOGY (2002)
Glutamate-induced excitotoxicity in retina: Neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers
JI Calzada et al.
NEUROCHEMICAL RESEARCH (2002)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
P Werner et al.
ANNALS OF NEUROLOGY (2001)
Oligodendrocyte killing by quinolinic acid in vitro
W Cammer
BRAIN RESEARCH (2001)
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt et al.
NATURE MEDICINE (2000)
Share Paper
